Digital Therapeutics Companies Make the Case for Pharma's Support

Pharma Companies Making 340B Restrictions Continue to Pile Up

Pharma Faces Sweeping Legislative Changes

FDA Authorizes Second COVID-19 Vaccine Booster

Prescription Drug Spending Debate Turns to Payers

FDA Calls on Drugmakers to Be 'Recall Ready'

Internet of Things Becomes Greater Focus for Pharma

Ukraine-Russia War Pushes Big Pharma Into Mixed Response